Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 5/20 | 0.42 |
| ▸ | ACE | P12821 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.36 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.36 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.36 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.35 |
| ▸ | ANPEP | P15144 | 3/20 | 0.35 |
| ▸ | GSTK1 | Q9Y2Q3 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6366305 | 0.90 | — | — | |
| SCHEMBL12092215 | 0.88 | FOLH1 (0.44) | FOLH1ACELMNAALKBH5SUCNR1 | |
| SCHEMBL40095 | 0.88 | FOLH1 (0.44) | FOLH1ACELMNAALKBH5SUCNR1 | |
| SCHEMBL13907082 | 0.88 | FOLH1 (0.44) | FOLH1ACELMNAALKBH5SUCNR1 | |
| SCHEMBL30505307 | 0.88 | FOLH1 (0.44) | FOLH1ACELMNAALKBH5SUCNR1 | |
| SCHEMBL39838 | 0.88 | FOLH1 (0.44) | FOLH1ACELMNAALKBH5SUCNR1 | |
| SCHEMBL18470513 | 0.87 | LMNA (0.47) | LMNAALKBH5SUCNR1EGLN1TSHR | |
| SCHEMBL2263857 | 0.82 | LMNA (0.42) | LMNAALKBH5SUCNR1EGLN1TSHR | |
| Mercaptopropionic Acid SCHEMBL331255 | 0.80 | ACE (0.50) | FOLH1ACELMNAALKBH5SUCNR1 | |
| SCHEMBL4166052 | 0.78 | TSHR (0.43) | LMNAALKBH5SUCNR1EGLN1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140213641-A1 | POLYMERIC NANOPARTICLES FOR DRUG DELIVERY | INSTITUT QUIMIC DE SARRIA (ES) | 2014-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140213641-A1 | POLYMERIC NANOPARTICLES FOR DRUG DELIVERY | CD44, MKI67, CD63 | FOLH1 1141/4885ACE 4232/4885LMNA 469/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.